Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure  Patricia Huelin, Salvatore Piano, Elsa Solà, Marialuisa Stanco, Cristina Solé, Rebeca Moreira, Elisa Pose, Silvano Fasolato, Nuria Fabrellas, Glòria de Prada, Chiara Pilutti, Isabel Graupera, Xavier Ariza, Antonietta Romano, Chiara Elia, Andrés Cárdenas, Javier Fernández, Paolo Angeli, Pere Ginès  Clinical Gastroenterology and Hepatology  Volume 15, Issue 3, Pages 438-445.e5 (March 2017) DOI: 10.1016/j.cgh.2016.09.156 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Individual values of SCr at baseline, at diagnosis of AKI, and peak value during hospitalization in patients with AKI stage 1A (A) and AKI stage 1B (B). Clinical Gastroenterology and Hepatology 2017 15, 438-445.e5DOI: (10.1016/j.cgh.2016.09.156) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 Frequency of type of AKI according to AKI stages. ATN, acute tubular necrosis; HRS, hepatorenal syndrome. Clinical Gastroenterology and Hepatology 2017 15, 438-445.e5DOI: (10.1016/j.cgh.2016.09.156) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Probability of 90-day transplant-free survival in patients with AKI stage 1 categorized into 2 groups according to SCr at diagnosis: 1A, SCr <1.5 mg/dL; 1B, SCr ≥1.5 mg/dL. Clinical Gastroenterology and Hepatology 2017 15, 438-445.e5DOI: (10.1016/j.cgh.2016.09.156) Copyright © 2017 AGA Institute Terms and Conditions